| 000 | 01586 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513131839.0 | ||
| 264 | 0 | _c19971230 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0001-6322 | ||
| 024 | 7 |
_a10.1007/s004010050740 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuattrini, A | |
| 245 | 0 | 0 |
_aAxonal neuropathy associated with interferon-alpha treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. _h[electronic resource] |
| 260 |
_bActa neuropathologica _cNov 1997 |
||
| 300 |
_a504-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAxons _xphysiology |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Direct |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xmetabolism |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInterferon Type I _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Fibers, Myelinated _xphysiology |
| 650 | 0 | 4 |
_aNeural Conduction _xphysiology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aSchwann Cells _xmetabolism |
| 650 | 0 | 4 |
_aSural Nerve _xpathology |
| 700 | 1 | _aComi, G | |
| 700 | 1 | _aNemni, R | |
| 700 | 1 | _aMartinelli, V | |
| 700 | 1 | _aVilla, A | |
| 700 | 1 | _aCaimi, M | |
| 700 | 1 | _aWrabetz, L | |
| 700 | 1 | _aCanal, N | |
| 773 | 0 |
_tActa neuropathologica _gvol. 94 _gno. 5 _gp. 504-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s004010050740 _zAvailable from publisher's website |
| 999 |
_c9356574 _d9356574 |
||